Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
426
Sources here
3
Companies here
22
Current section Mexico Healthcare news
Latest

finance.yahoo.com Capital return

Bekaert: Update on the Share Buyback Program and the Liquidity Agreement

Bekaert Update on the Share Buyback Program and the Liquidity Agreement Period from 6 August 2026 to 12 August 2026 Share Buyback Program On 26 February 2026, Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 75 million. As announced previously, the purpose of the …

Provider-linked mention 🇲🇽 Mexico
Read at finance.yahoo.com
Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6% BAYNN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

AFARAK GROUP: INTERIM REPORT H1 2026

Afarak Group SE 07:00 London, 09:00 Helsinki, 14 August 2026 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) FINANCIAL INTERIM RELEASE H1 2026 H1/26 H1/25 2025 Revenue EUR million 57.1 77.1 141.3 EBITDA EUR million 1.6 6.9 -0.2 EBIT EUR …

BAYNN mentioned
Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6% BAYNN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?

On July 22, Arcus Biosciences, Inc. (NYSE:RCUS) and Summit Therapeutics Inc. (NASDAQ:SMMT) announced a major clinical trial collaboration to combine Arcus's casdatifan (an investigational HIF-2α inhibitor) with Summit's ivonescimab (an investigational PD-1/VEGF bispecific antibody). The study aims to evaluate the safety and efficacy of …

SMMT main company
Sharemaestro market context Price below Trend Line 52 weeks -31.8% · Next-week setup negative 7.6% SMMT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?

On July 23, Genmab A/S (NASDAQ:GMAB) and AbbVie Inc. (NYSE:ABBV) clarified a key clinical setback regarding their jointly developed T-cell engaging bispecific antibody, epcoritamab (DuoBody-CD3xCD20). The Phase 3 EPCORE DLBCL-1 study evaluated epcoritamab monotherapy against investigator's choice of chemoimmunotherapy in transplant-ineligible adults with relapsed/refractory …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +8.3% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

MLP SE (WBO:MLP) (Q2 2026) Earnings Call Highlights: Record Revenue and EBIT Fuel Optimistic Outlook

This article first appeared on GuruFocus. Total Revenue: Increased by 10% to a record EUR583 million in the first half of 2026. EBIT: Reached a new record high of EUR64 million in the first half of 2026. Revenue by Competence Field: Property & Casualty …

BAYNN mentioned
Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6% BAYNN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

Johnson & Johnson (JNJ)’s $5.5B Talc Settlement: Turning Point or Temporary Relief?

The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from …

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +32.5% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?

HCA Healthcare, Inc. (NYSE:HCA) reported its second-quarter 2026 financial results on July 24, confirming the figures previewed earlier in the month. While top-line growth remained healthy, a visible deterioration in payer mix and a revision to full-year profitability guidance triggered immediate target cuts across …

SMMT mentioned
Sharemaestro market context Price below Trend Line 52 weeks -31.8% · Next-week setup negative 7.6% SMMT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine

Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc. (NASDAQ:GILD), are proving that in modern drug development, the biggest catalyst isn't always competing head-to-head; it is knowing when to join forces. While both companies reported their first-quarter 2026 earnings earlier this …

GILD main company
Sharemaestro market context Price below Trend Line 52 weeks +4.3% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates

HeartFlow (HTFL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $1.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

COO mentioned
Sharemaestro market context Price below Trend Line 52 weeks -10.9% · Next-week setup negative 25.0% COO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?

AbbVie Inc. (NYSE:ABBV) reported its first-quarter 2026 financial results, delivering worldwide net revenues of $15.002 billion, an increase of 12.4% on a reported basis (10.3% operationally). The company posted GAAP diluted EPS of $0.39 and adjusted diluted EPS of $2.65, which exceeded internal expectations …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +8.3% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Product Image (Photo: Bristol Myers Squibb)ZENBEXUS™ (iberdomide) Logo Approval based on EXCALIBER-RRMM results showing ZDd doubled minimal residual disease-negative complete response rates versus daratumumab, bortezomib and dexamethasone (41% vs. 21%) in relapsed or refractory multiple myeloma(1) ZENBEXUS marks the arrival of a new treatment …

BMY main company
Sharemaestro market context Trend signal started 52 weeks +23.9% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Merck (MRK) Stock Fair Value Edges Higher After Analysts Back Pipeline Progress

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Price target commentary for Merck has shifted toward a US$140 to US$155 range, anchored by a modest uplift in fair value from US$132.78 to …

MRK main company
Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Expands the solutions available to veterinarians to help address New World screwworm and gives added confidence for pet owners whose dogs and puppies are already receiving Simparica Trio Milestone demonstrates Zoetis' coordinated multi-species response to address New World screwworm across both companion animals and …

ZTS main company
Sharemaestro market context Price below Trend Line 52 weeks -56.9% ZTS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

How GE HealthCare’s New AI Ultrasound Launches Could Shape GEHC’s Diagnostic Edge for Investors

Earlier this month, GE HealthCare introduced the LOGIQ e Xi and LOGIQ e Si laptop ultrasound systems and launched the Invenia ABUS Prime and ABUS StreamVue breast imaging solutions, expanding its AI-enabled and cloud-connected ultrasound portfolio across multiple care settings. These product launches aim …

GEHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.3% GEHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish obesity-drug giant behind Wegovy and Ozempic, slipped approximately 1% Thursday morning as CEO Mike Doustdar tried to reset the market's thinking about the obesity race. His pitch: stop treating Novo versus Eli Lilly …

NOVOBN main company NVON main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% NOVOBN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered, while management narrowed its full-year outlook. The next test is execution. Stryker must keep normalizing production, convert elevated …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?

Novo Nordisk (NYSE: NVO) posted strong first-quarter results and performed fairly well in the month that followed its first-quarter update. However, the company's most recent financial update, for the second quarter, erased much of those gains. In both cases, the market's reaction was largely …

NOVOBN main company NVON main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% NOVOBN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

GEHC or LMAT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies …

GEHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.3% GEHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

Carolina Complete Health Supports Young Leaders Through AMEXCAN Summer Camp

Sponsorship helped 24 children from coastal North Carolina participate in educational, cultural and leadership-building activities CHARLOTTE, N.C., Aug. 13, 2026 /PRNewswire/ -- Carolina Complete Health, a subsidiary of the Centene Corporation (NYSE: CNC), sponsored the AMEXCAN Summer Camp, helping provide 24 children from coastal …

CNC main company
Sharemaestro market context Trend signal active 52 weeks +104.9% · Next-week setup negative 31.0% CNC stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Novo Nordisk (CPSE:NOVO B) Sees New Pressure In Weight Loss Drugs

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Novo Nordisk (CPSE:NOVO B) faces fresh competition as the UK's MHRA approves Eli Lilly's oral weight loss therapy Foundayo for use in the …

NOVOBN main company NVON main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% NOVOBN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
seekingalpha.com Capital return Main company 🇲🇽 Mexico

UnitedHealth faces shareholder suit accusing corporate governance failures

[UnitedHealthcare headquarters in Minnetonka, Minnesota, USA] JHVEPhoto/iStock Editorial via Getty Images UnitedHealth Group (UNH [https://seekingalpha.com/symbol/UNH]) is facing an amended shareholder lawsuit that accuses the insurer of knowing about serious governance issues and doing little to ensure compliance, leading to significant losses in stock value. …

UNH main company
Sharemaestro market context Trend signal active 52 weeks +21.8% UNH stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇲🇽 Mexico

Can Humana Improve Caregiver Retention With HealthStream Deal?

Humana Inc.'s HUM Medicaid managed care plan, Humana Healthy Horizons, is teaming up with HealthStream in Indiana to strengthen the state's home-care workforce. Under the initiative, Humana is sponsoring 1,000 Home Health Aide scholarships, helping remove financial barriers for people entering the caregiving field. …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +25.0% · Next-week setup negative 34.0% HUM stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and preeclampsia testing. Purpose-built for small to mid-sized laboratories and clinics, the platform is intended to bring reliable, rapid …

COO mentioned GMED mentioned
Sharemaestro market context Price below Trend Line 52 weeks -10.9% · Next-week setup negative 25.0% COO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation

Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the …

BIIB main company
Sharemaestro market context Trend signal active 52 weeks +53.6% · Next-week setup negative 26.4% BIIB stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇲🇽 Mexico

MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment

INDIANAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE: CNC) company, is proud to announce the recipients of the MHS Serves Workforce Support …

CNC main company
Sharemaestro market context Trend signal active 52 weeks +104.9% · Next-week setup negative 31.0% CNC stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -50.2% · Next-week setup negative 8.1% PODD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9% ABT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

SYK main company
Sharemaestro market context Price below Trend Line 52 weeks -19.4% · Next-week setup negative 43.7% SYK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

BD (BDX) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations - Shawn Bevec Chairman, Chief Executive Officer and President - Tom Polen Executive Vice President and Chief Financial Officer - Vitor Roque Full …

BDX main company
Sharemaestro market context Price below Trend Line 52 weeks -20.7% · Next-week setup negative 16.7% BDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
nasdaq.com Earnings Main company 🇲🇽 Mexico

Zoetis (ZTS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Steve FrankChief Executive Officer - Kristin PeckChief Financial Officer - Wetteny Joseph TAKEAWAYS Revenue -- $2.5 billion, representing a flat result on …

ZTS main company
Sharemaestro market context Price below Trend Line 52 weeks -56.9% ZTS stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Provider-linked mention 🇲🇽 Mexico

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

MeiraGTx Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 and reported positive three-year data from Phase 1 AQUAx clinical trial evaluating AAV2-hAQP1 for the treatment of moderate to severe grade 2/3 radiation-induced xerostomia Completed the acquisition of all interests and rights to botaretigene sparoparvovec (bota-vec) …

JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +32.5% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Capital return Main company 🇲🇽 Mexico

Why Gilead Sciences (GILD) Is Back In The Spotlight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Gilead Sciences (GILD) is back in focus after announcing a collaboration with Nucleai that applies AI powered tissue analytics to its antibody drug conjugate …

GILD main company
Sharemaestro market context Price below Trend Line 52 weeks +4.3% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

MDTN main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup negative 28.6% MDTN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical has seen its assessed fair value cut from US$107.42 to US$103.23, a modest 3.9% trim that reflects a cooler view on …

GMED main company
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2% GMED stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context